Compare Elastic NV (ESTC) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Elastic NV vs TransMedics Group Inc — how do they compare? Elastic NV trades at $98.23 (market cap $10.00B), while TransMedics Group Inc trades at $77.87 (market cap $2.74B). The key difference: Elastic NV is far larger — about 3.6× TransMedics Group Inc's market cap, and Elastic NV is trading nearer its 52-week high, TransMedics Group Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Elastic NV for 10 Days and TransMedics Group Inc for 24 Days on average.
| ESTC | TMDX | |
|---|---|---|
Market Cap | $10.00B | $2.74B |
Volume | 1,610,337 | 949,331 |
Sector | Technology | Health |
52-Week High | $99.91 | $150.42 |
52-Week Low | $43.30 | $61.99 |
Typical Hold Time | 10 Days | 24 Days |
Enterprise Value | $9.14B | $3.13B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Elastic (ESTC) trades at $95.26, up 2.32% today, with a bullish technical signal from moving averages but a neutral oscillator reading. The company reported strong earnings beats in recent quarters, with Q3 2026 results pending. Revenue grew to $1.48B in 2025, and net income is projected to turn positive in 2026. Recent news highlights product launches in AI and observability platforms, driving investor interest.
The outlook is positive, supported by analyst consensus and product innovation, but risks include high valuation multiples and competitive pressures. The stock offers growth potential if execution continues, though volatility near resistance levels may present short-term challenges.
TransMedics Group (TMDX) trades at $79.00, down 2.55% amid bearish technical signals and mixed earnings performance. The stock shows strong fundamentals with 58.69% gross margins and 22.69% net income margins, though profitability declined year-over-year. Recent news highlights insider buying, CFO appointment, and ongoing legal investigations into fiduciary duties, creating conflicting sentiment signals.
While analyst consensus remains bullish with a $99.75 price target, near-term risks include margin pressure from heavy investments and legal uncertainties. The stock's current valuation at 20.47 P/E offers potential upside if execution improves, but investors face volatility from earnings misses and regulatory scrutiny.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Elastic NV
Elastic NV provides a leading search AI platform built on Elasticsearch. Its software helps organizations find, observe, and protect data through search-powered analytics for various cloud-based applications.
Read more on ESTC →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
